Wankai New Materials Résultats passés
Passé contrôle des critères 0/6
Wankai New Materials's earnings have been declining at an average annual rate of -1.4%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 17.7% per year.
Informations clés
-1.4%
Taux de croissance des bénéfices
-7.6%
Taux de croissance du BPA
| Chemicals Croissance de l'industrie | 12.1% |
| Taux de croissance des recettes | 17.7% |
| Rendement des fonds propres | -2.4% |
| Marge nette | -0.8% |
| Dernière mise à jour des bénéfices | 30 Sep 2024 |
Mises à jour récentes des performances passées
Ventilation des recettes et des dépenses
Comment Wankai New Materials gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Sep 24 | 17,779 | -137 | 246 | 55 |
| 30 Jun 24 | 17,637 | 130 | 233 | 51 |
| 31 Mar 24 | 17,390 | 278 | 223 | 45 |
| 31 Dec 23 | 17,532 | 437 | 189 | 60 |
| 30 Sep 23 | 17,517 | 554 | 161 | 74 |
| 30 Jun 23 | 18,888 | 764 | 176 | 71 |
| 31 Mar 23 | 19,252 | 871 | 184 | 60 |
| 01 Jan 23 | 19,386 | 955 | 182 | 40 |
| 30 Sep 22 | 17,355 | 1,009 | 179 | 43 |
| 30 Jun 22 | 14,192 | 794 | 158 | 36 |
| 31 Mar 22 | 11,633 | 587 | 158 | 30 |
| 01 Jan 22 | 9,587 | 442 | 149 | 27 |
| 01 Oct 21 | 9,727 | 339 | 111 | 26 |
| 30 Jun 21 | 9,868 | 236 | 78 | 25 |
| 31 Mar 21 | 10,246 | 297 | 171 | 24 |
| 31 Dec 20 | 9,298 | 203 | 146 | 18 |
| 31 Dec 19 | 9,682 | 367 | 158 | 13 |
| 31 Dec 18 | 11,725 | 196 | 216 | 11 |
| 31 Dec 17 | 8,681 | 107 | 140 | 8 |
Des revenus de qualité: 301216 is currently unprofitable.
Augmentation de la marge bénéficiaire: 301216 is currently unprofitable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: 301216 is unprofitable, and losses have increased over the past 5 years at a rate of 1.4% per year.
Accélération de la croissance: Unable to compare 301216's earnings growth over the past year to its 5-year average as it is currently unprofitable
Bénéfices par rapport au secteur d'activité: 301216 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-3.8%).
Rendement des fonds propres
ROE élevé: 301216 has a negative Return on Equity (-2.4%), as it is currently unprofitable.